Not sure about that, MSB's cells are already on the market for treatment of aGVHD in Japan and will more than likely be approved in the US soon without needing a partnership. Great news for CYP though, hopefully you avoid making a number of the mistakes MSB has and the path there is somewhat less rocky. CYP has a lot of room to move north with its current MC too.
Theres plenty of room in the market for both companies
Not sure about that, MSB's cells are already on the market for...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.005(2.00%) |
Mkt cap ! $45.80M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 25.5¢ | 25.5¢ | $313 | 1.229K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 22209 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 36715 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |